Leroy R. Lard

2.0k total citations
25 papers, 1.5k citations indexed

About

Leroy R. Lard is a scholar working on Rheumatology, Hematology and Genetics. According to data from OpenAlex, Leroy R. Lard has authored 25 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Rheumatology, 11 papers in Hematology and 8 papers in Genetics. Recurrent topics in Leroy R. Lard's work include Rheumatoid Arthritis Research and Therapies (14 papers), Systemic Lupus Erythematosus Research (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Leroy R. Lard is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (14 papers), Systemic Lupus Erythematosus Research (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Leroy R. Lard collaborates with scholars based in Netherlands, Curacao and United States. Leroy R. Lard's co-authors include I. Speyer, T. Huizinga, Henk Visser, Ferdinand C. Breedveld, Aeilko H. Zwinderman, Johanna M. W. Hazes, Ashley J. Duits, René E. M. Toes, Cornelia F Allaart and Masja de Haas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The American Journal of Medicine and Annals of the Rheumatic Diseases.

In The Last Decade

Leroy R. Lard

25 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leroy R. Lard Netherlands 16 998 536 425 208 187 25 1.5k
M V van Krugten Netherlands 14 1.7k 1.7× 640 1.2× 336 0.8× 428 2.1× 174 0.9× 19 2.1k
A. Gerards Netherlands 14 1.7k 1.7× 749 1.4× 383 0.9× 336 1.6× 148 0.8× 29 2.0k
M L Westedt Netherlands 16 1.6k 1.6× 536 1.0× 282 0.7× 388 1.9× 251 1.3× 34 1.9k
J.H.L.M. van Groenendael Netherlands 16 1.9k 1.9× 744 1.4× 406 1.0× 324 1.6× 175 0.9× 22 2.1k
Simone Baldovino Italy 24 654 0.7× 229 0.4× 226 0.5× 267 1.3× 125 0.7× 73 1.5k
M. J. van der Veen Netherlands 14 1.3k 1.3× 472 0.9× 328 0.8× 144 0.7× 91 0.5× 16 1.5k
M. P. M. van der Linden Netherlands 13 1.1k 1.1× 277 0.5× 122 0.3× 174 0.8× 209 1.1× 16 1.3k
S. Kary Germany 19 1.6k 1.6× 668 1.2× 223 0.5× 876 4.2× 166 0.9× 23 2.2k
Loukas Settas Greece 16 819 0.8× 358 0.7× 134 0.3× 349 1.7× 111 0.6× 28 1.2k
Hilde Swinkels Netherlands 8 1.2k 1.2× 320 0.6× 125 0.3× 164 0.8× 237 1.3× 9 1.3k

Countries citing papers authored by Leroy R. Lard

Since Specialization
Citations

This map shows the geographic impact of Leroy R. Lard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leroy R. Lard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leroy R. Lard more than expected).

Fields of papers citing papers by Leroy R. Lard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leroy R. Lard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leroy R. Lard. The network helps show where Leroy R. Lard may publish in the future.

Co-authorship network of co-authors of Leroy R. Lard

This figure shows the co-authorship network connecting the top 25 collaborators of Leroy R. Lard. A scholar is included among the top collaborators of Leroy R. Lard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leroy R. Lard. Leroy R. Lard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Moel, Emma C. de, V. Derksen, Leendert A. Trouw, et al.. (2019). In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response. Arthritis Research & Therapy. 21(1). 28–28. 45 indexed citations
4.
Heimans, L., Sytske Anne Bergstra, Robbert J Goekoop, et al.. (2017). Clinical and radiological outcomes of 5-year drug-free remission-steered treatment in patients with early arthritis: IMPROVED study. Annals of the Rheumatic Diseases. 77(1). 111–118. 52 indexed citations
5.
Heimans, L., Yvonne P M Goekoop-Ruiterman, J.H.L.M. van Groenendael, et al.. (2016). Two-year results of disease activity score (DAS)-remission-steered treatment strategies aiming at drug-free remission in early arthritis patients (the IMPROVED-study). Arthritis Research & Therapy. 18(1). 23–23. 36 indexed citations
6.
Verheul, Marije K., L. Heimans, Yvonne P M Goekoop-Ruiterman, et al.. (2016). Predictive factors of radiological progression after 2 years of remission-steered treatment in early arthritis patients: a post hoc analysis of the IMPROVED study. RMD Open. 2(1). e000172–e000172. 12 indexed citations
7.
Heimans, L., Marije K. Verheul, Anne A. Schouffoer, et al.. (2014). Radiological Outcomes after Two Years of Remission Steered Treatment in Early Arthritis Patients. Data Archiving and Networked Services (DANS). 66. 1 indexed citations
8.
Lard, Leroy R., Paul J. M. van der Boog, Maud Veseliç, et al.. (2008). A pitfall in screening with decoy cells after simultaneous pancreas kidney transplantation. Clinical Transplantation. 22(6). 833–836. 2 indexed citations
9.
Aken, Jill van, Leroy R. Lard, Karen Visser, et al.. (2007). Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: A double‐blind, randomized, placebo‐controlled trial. Arthritis & Rheumatism. 56(5). 1424–1432. 290 indexed citations
10.
Jansen, L M A, Irene E. van der Horst‐Bruinsma, Dirkjan van Schaardenburg, et al.. (2004). Comparison of the baseline disease activity of early oligo- and polyarthritis in sequential years.. PubMed. 22(4). 447–52. 6 indexed citations
11.
Toes, René E. M., Heleen van Dongen, Leroy R. Lard, et al.. (2004). Cellular-based immune modulation in arthritis. Arthritis Research. 6(Suppl 3). 18–18. 1 indexed citations
12.
Lard, Leroy R., Joris Schonkeren, Elsbet Pieterman, et al.. (2003). Association of the –2849 interleukin‐10 promoter polymorphism with autoantibody production and joint destruction in rheumatoid arthritis. Arthritis & Rheumatism. 48(7). 1841–1848. 49 indexed citations
13.
Lard, Leroy R., Maarten Boers, Arco C. Verhoeven, et al.. (2002). Early and aggressive treatment of rheumatoid arthritis patients affects the association of HLA class II antigens with progression of joint damage. Arthritis & Rheumatism. 46(4). 899–905. 57 indexed citations
14.
Lard, Leroy R., Bart O. Roep, Cornelis A. Verburgh, A. H. Zwinderman, & T. Huizinga. (2002). Elevated IL-16 levels in patients with systemic lupus erythematosus are associated with disease severity but not with genetic susceptibility to lupus. Lupus. 11(3). 181–185. 33 indexed citations
15.
Lard, Leroy R., Henk Visser, I. Speyer, et al.. (2001). Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. The American Journal of Medicine. 111(6). 446–451. 457 indexed citations
16.
Lard, Leroy R., T. Huizinga, Johanna M W Hazes, & T. P. M. Vliet Vlieland. (2001). Delayed referral of female patients with rheumatoid arthritis.. PubMed. 28(10). 2190–2. 36 indexed citations
17.
Schnog, John‐John B., Arnon P. Kater, Melvin R. Mac Gillavry, et al.. (2001). Low adjusted‐dose acenocoumarol therapy in sickle cell disease: A pilot study. American Journal of Hematology. 68(3). 179–183. 29 indexed citations
18.
Schnog, John‐John B., Leroy R. Lard, R.A. Rojer, et al.. (1998). New concepts in assessing sickle cell disease severity. American Journal of Hematology. 58(1). 61–66. 42 indexed citations
19.
Schnog, John‐John B., et al.. (1998). New concepts in assessing sickle cell disease severity. American Journal of Hematology. 58(1). 61–66. 4 indexed citations
20.
Duits, Ashley J., John‐John B. Schnog, Leroy R. Lard, A.W. Saleh, & R.A. Rojer. (1998). Elevated IL‐8 levels during sickle cell crisis. European Journal Of Haematology. 61(5). 302–305. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M V van Krugten Breakdown of academic impact, for papers by A. Gerards Breakdown of academic impact, for papers by M L Westedt Breakdown of academic impact, for papers by J.H.L.M. van Groenendael Breakdown of academic impact, for papers by Simone Baldovino Breakdown of academic impact, for papers by M. J. van der Veen Breakdown of academic impact, for papers by M. P. M. van der Linden Breakdown of academic impact, for papers by S. Kary Breakdown of academic impact, for papers by Loukas Settas Breakdown of academic impact, for papers by Hilde Swinkels
Rankless by CCL
2026